Stockreport

Eyenovia Provides Clinical and Scientific Update on FDA-Approved Products Mydcombi™ and Clobetasol Propionate Ophthalmic Suspension [Yahoo! Finance]

Eyenovia, Inc.  (EYEN) 
Last eyenovia, inc. earnings: 3/25 04:05 pm Check Earnings Report
PDF Also announces upcoming ARVO presentation on the unique technology behind clobetasol that allows for future ophthalmic suspensions to be dispensed with the Optejet® N [Read more]